Location History:
- Indianapolis, IN (US) (2019)
- San Diego, CA (US) (2021)
Company Filing History:
Years Active: 2019-2021
Title: Innovations by Carlos A Labarrere in Cardiac Allograft Rejection
Introduction
Carlos A Labarrere is a notable inventor based in San Diego, CA, who has made significant contributions to the field of cardiac health. He holds two patents that focus on methods for diagnosing and reducing incidences of cardiac allograft rejection. His work is crucial for improving the outcomes of heart transplant recipients.
Latest Patents
Labarrere's latest patents include "Methods for diagnosing and reducing incidences of cardiac allograft rejection" and "Substances, vaccines and methods for diagnosing and reducing incidences of transplant rejection." The first patent outlines a noninvasive method for screening cardiac allograft recipients for risks of developing cardiac allograft vasculopathy. This method involves withdrawing biological samples and analyzing them for biomarkers indicative of fibrin deposits within the cardiac allograft microvasculature. The detection of these biomarkers signals that the recipient may be at risk for developing complications. The second patent describes a method for screening allograft recipients, including pregnant women, for chronic allograft rejection by measuring natural antibodies in biological samples. A decrease in these antibodies compared to control samples indicates a risk of rejection. Additionally, it includes a composition for preventing or treating chronic allograft rejection, which comprises a therapeutically effective amount of phosphorylcholine.
Career Highlights
Carlos A Labarrere is associated with 3DT Holdings, LLC, where he continues to innovate in the medical field. His work is characterized by a strong focus on improving transplant outcomes and patient care.
Collaborations
Labarrere collaborates with Ghassan S Kassab, contributing to advancements in cardiac health and transplant medicine.
Conclusion
Carlos A Labarrere's innovative patents and dedication to improving cardiac allograft outcomes highlight his significant role in medical advancements. His contributions are vital for enhancing the quality of life for heart transplant recipients.